[Economic impact of management strategies for streptococcal B cervico-vaginal infections during pregnancy]

J Gynecol Obstet Biol Reprod (Paris). 1997;26(3 Suppl):42-7.
[Article in French]
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / economics
  • Cost of Illness*
  • Cost-Benefit Analysis
  • Female
  • Health Care Costs*
  • Humans
  • Mass Screening / economics
  • Pregnancy
  • Pregnancy Complications, Infectious / economics*
  • Pregnancy Complications, Infectious / prevention & control
  • Pregnancy Outcome
  • Streptococcal Infections / economics*
  • Streptococcal Infections / prevention & control
  • Streptococcus agalactiae*
  • Uterine Cervical Diseases / economics*
  • Uterine Cervical Diseases / prevention & control
  • Vaginal Diseases / economics*
  • Vaginal Diseases / prevention & control

Substances

  • Anti-Bacterial Agents